Invention Grant
- Patent Title: Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof
-
Application No.: US15439531Application Date: 2017-02-22
-
Publication No.: US10323061B2Publication Date: 2019-06-18
- Inventor: Yat Sun Or , Jing He , Guoqiang Wang , Xuechao Xing
- Applicant: ENANTA PHARMACEUTICALS, INC.
- Applicant Address: US MA Watertown
- Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore, Esq.
- Main IPC: C07J43/00
- IPC: C07J43/00 ; A61K31/58
Abstract:
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated by FXR and/or TGR5.
Public/Granted literature
- US20170240587A1 HETEROARYL CONTAINING BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF Public/Granted day:2017-08-24
Information query
